This site is intended only for healthcare professionals resident in the Republic of Ireland




Sign in or registerLog out
Our medicinesTherapy areasExplore contentExplore contentMaterialsVideosPodcastsLet’s connectLet's connectContact usSign up



AboutAboutAntibacterialsAntifungalsAntimicrobial Resistance(AMR)Our CommitmentOur CommitmentPfizer’s Heritage in AMR

Pfizer has a long-standing commitment to tackling antimicrobial resistance (AMR), as well as a willingness to collaborate with external stakeholders. Initiatives currently focus on an extensive range of programmes that go beyond the sale of our medicines, including; public awareness and educational programmes, education of healthcare professionals, responsible commercial and manufacturing activities and investment in surveillance programmes.

Pfizer is proud to have been recognized as the joint industry leader in the Access to Medicine Foundation’s 2021 AMR Benchmark Report, with the report highlighting our industry-leading policies to improve appropriate access to our medicines and curb the threat of AMR. We performed strongly in R&D, Responsible Manufacturing and Appropriate Access, were ranked leaders in Stewardship, and were commended for being the first pharmaceutical company to publicly share raw surveillance data from our antimicrobial surveillance website platform, the Antimicrobial Testing Leadership and Surveillance (ATLAS) database.1

Antifungals About Antifungals Loading Antibacterials About Antibacterials Loading Antimicrobial Resistance What is AMR? Loading Pfizer Heritage Pfizer Heritage in AMR LoadingReferences:Access to Medicine Foundation. Antimicrobial resistance benchmark 2021. Available at: Last accessed January 2023
PP-UNP-IRL-0347 Date of Preparation : January 2023

Adverse events should be reported. Report an adverse event to your national reporting system (HPRA Pharmacovigilance)

Adverse events should also be reported to Pfizer Medical Information on 1800 633 363

PfizerPro AccountPfizerPro Account

Please sign in or register to gain access to information relating to Pfizer medicines and vaccines, medical conditions, patient materials and services.

Sign in or RegisterRegisterAccountLog out

This site is intended only for healthcare professionals resident in the Republic of Ireland. If you are a member of the public wishing to access information on a specific medicine, please visit


This website is brought to you by Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24, Ireland. Registered in the Republic of Ireland No. 127002.


Copyright © 2024 Pfizer Limited. All rights reserved.

PP-UNP-IRL-0733. March 2024
For Healthcare Professionals in the Republic of Ireland *

The information on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland and contains promotional content.

I confirm that I am a healthcare professional* resident in the Republic of Ireland.

If you select 'No', you will be redirected to, where you will be able to access information on Pfizer Healthcare Ireland.

*The IPHA Code definition of a healthcare profressional is a person of any of the following classes: (i) Registered medical practitioners (ii) Registered dentists (iii) Registered pharmacists (iv) Registered nurses

Terms of use

PP-UNP-IRL-0733 . March 2024

Yes No
You are now leaving PfizerPro
You are now leaving PfizerPro Ireland. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer. Pfizer accepts no responsibility for the content or services of the linked site.

PP-UNP-IRL-0733. March 2024